Security · CUSIP 02043QAB3
ALNYLAM PHARMACEUTICALS INC
NOTE 1.000% 9/1 · institutional ownership from 13F filings
13F holders
7
Shares held
9.0M
Value held
$11.7M
New / sold out
1 / 2
Added / reduced
2 / 0
net +2.7M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q2 2025
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 4,950,000 | $6.4M | 0.02% |
| STATE OF WISCONSIN INVESTMENT BOARD | 2,000,000 | $2.6M | 0.01% |
| Bank of New York Mellon Corp | 1,700,000 | $2.2M | 0.00% |
| SEI INVESTMENTS CO | 251,000 | $326.0K | 0.00% |
| OPPENHEIMER ASSET MANAGEMENT INC. | 79,000 | $102.6K | 0.00% |
| STEPHENS INC /AR/ | 24,000 | $31.2K | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | – |
Biggest buyers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| STATE OF WISCONSIN INVESTMENT BOARD | New | +2,000,000 | – |
| Bank of New York Mellon Corp | Added | +700,000 | +70.0% |
| STEPHENS INC /AR/ | Added | +2,000 | +9.1% |
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| NOMURA HOLDINGS INC | Sold out | -1,528 | -100.0% |
| LOOMIS SAYLES & CO L P | Sold out | -594 | -100.0% |